Re: futility
|
3
|
Resverlogix Corp.
|
Nov 07, 2016 12:12AM
|
Re: futility
|
7
|
Resverlogix Corp.
|
Nov 07, 2016 12:11PM
|
Re: futility ... comments/thoughts...
|
4
|
Resverlogix Corp.
|
Nov 08, 2016 02:30PM
|
Re: Futility analysis
|
6
|
Resverlogix Corp.
|
Feb 08, 2017 10:48AM
|
Re: Futility Analysis
|
5
|
Resverlogix Corp.
|
Feb 18, 2016 11:55AM
|
Re: Futility Analysis - Digging Deeper
|
4
|
Resverlogix Corp.
|
Feb 19, 2016 12:23PM
|
Re: Futility Analysis - Digging Deeper
|
4
|
Resverlogix Corp.
|
Feb 19, 2016 03:24PM
|
Re: Futility Analysis Q&A With Company Source
|
4
|
Resverlogix Corp.
|
Feb 18, 2016 09:06PM
|
Re: Future Trials
|
2
|
Resverlogix Corp.
|
Feb 14, 2020 09:18AM
|
Re: Future Trials
|
2
|
Resverlogix Corp.
|
Feb 14, 2020 01:36PM
|
Re: FXR and liver transaminase related adverse events
|
4
|
Resverlogix Corp.
|
Sep 19, 2018 06:58AM
|
Re: FXR and liver transaminase related adverse events
|
5
|
Resverlogix Corp.
|
Oct 03, 2018 11:32AM
|
Re: FXR and liver transaminase related adverse events
|
2
|
Resverlogix Corp.
|
Oct 03, 2018 11:47AM
|
Re: FXR and liver transaminase related adverse events
|
5
|
Resverlogix Corp.
|
Oct 03, 2018 01:41PM
|
Re: FYI... first quarter RVX events section...
|
5
|
Resverlogix Corp.
|
Jan 21, 2016 01:59PM
|
Re: Games being played on the share price
|
4
|
Resverlogix Corp.
|
May 01, 2019 04:56PM
|
Re: Games being played on the share price
|
3
|
Resverlogix Corp.
|
May 01, 2019 08:35PM
|
Re: Gasoline
|
3
|
Zenith Epigenetics
|
Feb 09, 2017 02:15PM
|
Re: Genentech/Roche BET inhibitor toxicity paper
|
6
|
Resverlogix Corp.
|
Apr 20, 2016 11:12AM
|
Re: General360
|
5
|
Resverlogix Corp.
|
Jun 21, 2017 03:52PM
|